Akyerli, C. B., & Deimling, A. v. (2017). Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas. Journal of neurosurgery, 128(4), .
Chicago-Zitierstil (17. Ausg.)Akyerli, Cemaliye B., und Andreas von Deimling. "Use of Telomerase Promoter Mutations to Mark Specific Molecular Subsets with Reciprocal Clinical Behavior in IDH Mutant and IDH Wild-type Diffuse Gliomas." Journal of Neurosurgery 128, no. 4 (2017).
MLA-Zitierstil (9. Ausg.)Akyerli, Cemaliye B., und Andreas von Deimling. "Use of Telomerase Promoter Mutations to Mark Specific Molecular Subsets with Reciprocal Clinical Behavior in IDH Mutant and IDH Wild-type Diffuse Gliomas." Journal of Neurosurgery, vol. 128, no. 4, 2017.